Presentations

Investor presentation, 2 February 2017
Poster at Rettsyndrome.org 2016 Rett Syndrome Symposium
Improving outcome measures for Rett Syndrome (RTT) clinical trials: Development of CSS/MBA change indexes to assess treatment outcome
Presentation by Daniel Glaze, MD, at Rettsyndrome.org 2016 Rett Syndrome Symposium
Past, Present and Future: A program to develop and establish Trofinetide as a safe and effective treatment for Rett syndrome
Presentation at 6th Annual TBI Conference, Washington DC
A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of NNZ-2566 in Patients with Traumatic Brain Injury
Poster at American Academy of Neurology 2015 Annual Meeting
NNZ-2566: A Novel, Experimental Treatment for Rett Syndrome
Poster at International Meeting for Autism Research (IMFAR)
Improving outcome measures for Rett Syndrome (RTT) clinical trials: the development of RTT-specific anchors for the Clinical Global Impression Scale
Poster at 2013 FRAXA Investigators Meeting
The Impact of NNZ-2591 on the fmr1 Knockout Mouse Model of Fragile X Syndrome
Poster at American Neuropsychiatric Association 2013 Annual Meeting
The Impact of NNZ-2566 on the fmr1 Knockout Mouse Model of Fragile X Syndrome
Presentation by Dr Mike Snape at ICare4Autism 2012 International Autism Conference
NNZ-2566 - Rationale for use in Autism Spectrum Disorders